Duloxetine hydrochloride
CAS No. 136434-34-9
Duloxetine hydrochloride( LY248686 )
Catalog No. M11501 CAS No. 136434-34-9
Duloxetine hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor .
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 43 | In Stock |
|
| 50MG | 70 | In Stock |
|
| 100MG | 97 | In Stock |
|
| 200MG | 122 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDuloxetine hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionDuloxetine hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor .
-
DescriptionDuloxetine hydrochloride is a selective serotonin and norepinephrine reuptake inhibitor .(In Vitro):Duloxetine ((S)-Duloxetine hydrochloride) (sold under the brand names Cymbalta, Ariclaim, Xeristar, Yentreve, Duzela, Dulane) is a serotonin-norepinephrine reuptake inhibitor(SNRI) manufactured and marketed by Eli Lilly. It is prescribed for major depressive disorder and generalized anxiety disorder (GAD). Duloxetine also has approval for use in osteoarthiritis and musculoskeletal pain. Duloxetine failed the US approval for stress urinary incontinence amidst concerns over liver toxicity and suicidal events; however, it was approved for this indication in Europe, where it is recommended as an add-on medication in stress urinary incontinence instead of surgery. It can also relieve the symptoms of painful peripheral neuropathy, particularly diabetic neuropathy, and it is used to control the symptoms of fibromyalgia. The main uses of duloxetine are in major depressive disorder, general anxiety disorder, stress urinary incontinence, painful peripheral neuropathy,fibromyalgia, and chronic musculoskeletal pain associated with osteoarthritis and chronic lower back pain. It is being studied for various other indications.
-
In VitroDuloxetine ((S)-Duloxetine hydrochloride) (sold under the brand names Cymbalta, Ariclaim, Xeristar, Yentreve, Duzela, Dulane) is a serotonin-norepinephrine reuptake inhibitor(SNRI) manufactured and marketed by Eli Lilly. It is prescribed for major depressive disorder and generalized anxiety disorder (GAD). Duloxetine also has approval for use in osteoarthiritis and musculoskeletal pain. Duloxetine failed the US approval for stress urinary incontinence amidst concerns over liver toxicity and suicidal events; however, it was approved for this indication in Europe, where it is recommended as an add-on medication in stress urinary incontinence instead of surgery. It can also relieve the symptoms of painful peripheral neuropathy, particularly diabetic neuropathy, and it is used to control the symptoms of fibromyalgia. The main uses of duloxetine are in major depressive disorder, general anxiety disorder, stress urinary incontinence, painful peripheral neuropathy,fibromyalgia, and chronic musculoskeletal pain associated with osteoarthritis and chronic lower back pain. It is being studied for various other indications.
-
In Vivo——
-
SynonymsLY248686
-
PathwayEndocrinology/Hormones
-
Target5-HT Receptor
-
RecptorSert (Sodium-dependent)| DA transporter| Noradrenaline transporter (Sodium-dependent)
-
Research AreaNeurological Disease
-
Indication——
Chemical Information
-
CAS Number136434-34-9
-
Formula Weight333.88
-
Molecular FormulaC18H20ClNOS
-
Purity>98% (HPLC)
-
SolubilityDMSO: 67 mg/mL (200.67 mM)
-
SMILESCNCC[C@@H](C1=CC=CS1)OC2=CC=CC3=CC=CC=C32
-
Chemical Name(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Chen F, et al. Eur Neuropsychopharmacol. 2005 Mar; 15(2):193-8.
molnova catalog
related products
-
Ro 67-7476
Ro 67-7476 is a positive allosteric modulator of mGlu1 receptors. No activity at human mGlu1 receptors. Potentiates glutamate-induced calcium release with EC 50 of 60.1 nM.
-
Vortioxetine (Lu AA2...
Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT.
-
Temanogrel
Temanogrel is a highly selective antagonist of the 5-HT2A receptor (Ki: 4.9 nM).
Cart
sales@molnova.com